Journal
ARCHIVES OF INTERNAL MEDICINE
Volume 168, Issue 21, Pages 2340-2346Publisher
AMER MEDICAL ASSOC
DOI: 10.1001/archinte.168.21.2340
Keywords
-
Categories
Funding
- PETROBRAS-FINEP
- Brazilian National Research Council
Ask authors/readers for more resources
Background: The prognostic value of office and ambulatory blood pressures (BPs) in patients with resistant hypertension is uncertain. Methods: This prospective study investigates the importance of office and ambulatory BPs as predictors of cardiovascular morbidity and mortality. At baseline, 556 resistant hypertensive patients underwent clinical-laboratory and 24-hour ambulatory BP monitoring examinations. Primary end points were a composite of fatal and nonfatal cardiovascular events and all-cause and cardiovascular mortalities. Multiple Cox regression was used to assess associations between BP and subsequent end points. Results: After median follow-up of 4.8 years, 109 patients ( 19.6%) reached the primary end point, and 70 all-cause deaths ( 12.6%) occurred ( 46 had cardiovascular causes). After adjustment for age, sex, body mass index, diabetes mellitus, smoking, physical inactivity, dyslipidemia, previous cardiovascular diseases, serum creatinine level, and number of antihypertensive drugs in use, no office BP showed any prognostic value. After further adjustment for office BP, higher mean ambulatory BPs were independent predictors of the composite end point. The hazard ratios associated with a 1-SD increment in daytime and nighttime systolic BP were 1.26 ( 95% confidence interval, 1.04-1.53) and 1.38 ( 1.13-1.68), respectively; the corresponding values for diastolic BP were 1.31 ( 1.05-1.63) and 1.36 ( 1.10-1.69). Ambulatory systolic and diastolic BP were equivalent predictors, and both were better than pulse pressure; nighttime BP was superior to daytime BP. For all-cause mortality, only the ambulatory BP monitoring diagnosis of true resistant hypertension was an independent predictor. Conclusion: Higher ambulatory BP predicts cardiovascular morbidity and mortality in resistant hypertensive patients, whereas office BP has no prognostic value.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available